Catalyst Wire Dossier Catalyst Wire Dossier

Spravato (esketamine nasal spray)

Esketamine · Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Spravato (esketamine nasal spray), covering 2020-10-29 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression

See pricing